Resident CD11c+ Lung Cells Are Impaired by Anthrax Toxins after Spore Infection
1Unité d’Immunobiologie, Département de Biologie des Agents Transmissibles, and 2Unité de Radiobiologie et Inflammation, Département de Radiobiologie et de Radiopathologie, Centre de Recherche du Service de Santé des Armées, La Tronche, France
Bacillus anthracis secretes 2 toxins: lethal toxin (LT) and edema toxin (ET). We investigated their role in the physiopathologic mechanisms of inhalational anthrax by evaluating murine lung dendritic cell (LDC) functions after infection with B. anthracis strains secreting LT, ET, or both or with a nontoxinogenic strain. Three lung cell populations gated on CD11c/CD11b expression were obtained after lung digestion: (1) CD11chigh/CD11blow (alveolar macrophages), (2) CD11cintermediate (int)/CD11bint (LDCs), and (3) CD11clow/CD11bhigh (interstitial macrophages or monocytes). After infection with LT‐secreting strains, a decrease in costimulatory molecule expression on LDCs was observed. All CD11c+ cells infected with a nontoxinogenic strain secreted tumor necrosis factor (TNF)–α, interleukin (IL)–10, and IL‐6. LT‐secreting strains inhibited overall cytokine secretion, whereas the ET‐secreting strain inhibited only TNF‐α secretion and increased IL‐6 secretion. Similar results were obtained after preincubation with purified toxins. Our results suggest that anthrax toxins secreted during infection impair LDC function and suppress the innate immune response.
Received 18 November 2005; accepted 4 February 2006; electronically published 26 May 2006.
Cited by
Online publication date: 1-Mar-2009.
CrossRef
Online publication date: 1-Feb-2009.
CrossRef
Online publication date: 1-Jan-2009.
CrossRef
Online publication date: 1-Jun-2008.
CrossRef
Online publication date: 1-Jun-2008.
CrossRef
Online publication date: 1-Apr-2007.
CrossRef
Online publication date: 1-Jan-2007.
CrossRef
-
Presented in part: 12th International Congress of Mucosal Immunology, Boston, MA, 25–30 June 2005 (abstract 53928).
Potential conflicts of interest: none reported.
Financial support: Délégation Générale pour l’Armement (grant CO 010808); Service de Santé des Armées (135OP3B LFR EMA).





